Search
XNAS • Healthcare

Aptevo Therapeutics Inc (APVO)

PHARMACEUTICAL PREPARATIONS · 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121

XNASstockActive listing
1.60
-0.02 (-1.23%)
Quote updated 10/19/2026, 4:00:00 AM
Previous close1.62
Open1.65
Day range1.57 – 1.65
52-week range1.37 – 29.70
Volume8,400
Market cap3.26M
PRICE HISTORY

Stock price history and performance

Daily closing prices from the stored market history.

250 sessions
$30$23$15$7$-1Oct 21Apr 21Oct 19
STOCK RESEARCH · EDITORIAL ANALYSIS

Aptevo Therapeutics Inc (APVO): Investment Research & Business Outlook

A research-led explanation of the company, its financial evidence, valuation context and risks—not just a list of market numbers.

Research note

What the available evidence tells us

The latest stored quote for Aptevo Therapeutics Inc (APVO) is 1.60, timestamped 10/19/2026, 4:00:00 AM. A quote is a point-in-time observation; it does not, by itself, explain why the price moved or establish whether the shares are attractive.

Business and financial quality

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Stored fundamentals include 26 usable headline metrics. These should be read across several reporting periods and compared with peers before drawing a conclusion about business quality.

Valuation: context matters

The stored trailing P/E ratio is 1.14. P/E compares a company’s share price with its earnings, but it should be interpreted alongside expected growth, earnings quality, cyclicality and comparable companies.

Price trend and quantitative outlook

The chart is based on 250 stored daily price observations. Historical performance describes what happened over that period; it is not a guarantee of future returns. The current stored quantitative model signal is “neutral”. Treat model outputs as scenarios with uncertainty, not as certain targets or personalized advice.

Key risks and what to watch next

Risk records exist for this company; review the risk and performance section below for the available volatility, drawdown and risk-adjusted measures. The next useful evidence to review is the company’s next reported financial results, changes in forward estimates, and primary-source disclosures.

Editorial integrity: this summary uses fields available in the current database. Missing evidence is called out rather than filled with invented facts.

What the numbers mean for investors

Business quality

A reliable revenue-growth reading is not available or is not positive in the latest stored snapshot. Review multiple reporting periods before judging the growth trajectory.

Profitability

Margin data is incomplete. Revenue alone cannot show whether the company converts sales into sustainable profit.

Valuation

The stored P/E is 1.14. A multiple is not a verdict by itself: interpret it alongside expected earnings growth, cyclicality, cash flow, and comparable companies.

Price trend

The latest quote can be compared with the 20-, 50- and 200-day moving averages (1.79, 2.17, and 4.70). Moving averages describe trend, not intrinsic value, and can lag sudden market changes.

Bull case, bear case and evidence to watch

Bull case

The bullish case needs confirmation from reported revenue growth, cash generation, and future company disclosures; the current snapshot does not establish those conditions together.

Bear case

Potential downside still includes weaker demand, margin compression, competition, execution issues, or a broad market sell-off. Company-specific evidence is needed to quantify these risks.

What to watch next

Track the next earnings release, changes in revenue and margin trends, cash flow, management guidance, analyst estimate revisions, and primary-source filings. Update the thesis when new evidence arrives rather than relying on one ratio or forecast.

These interpretations are rule-based explanations of the stored fields, not independently verified company-specific forecasts. Missing data is not treated as zero; all investment cases remain conditional on new evidence.

US Market AI Research Desk · Data/research timestamp: Oct 19, 2026 · Methodology & disclaimer
QUANTITATIVE RESEARCH

Stock forecast and analysis: price outlook

Forecasts are model outputs, not promises or personalized investment advice.

neutral
HorizonModel targetExpected changeSignalConfidence score
24H1.59-0.81%neutral80
7D1.55-3.05%bearish80
30D1.47-8.18%bearish80
90D1.34-16.10%bearish80

Long-term model scenarios

Latest stored scenario per future target year. Bear, base and bull prices are model scenarios, not guaranteed targets. The relative model score is not a calibrated probability; uncertainty rises materially for distant years.

Target yearBase caseBear caseBull caseExpected CAGRRelative model scoreSignal
20271.821.821.821.35%67long-term-neutral
20301.961.912.002.18%66long-term-positive
20352.352.152.563.03%65long-term-positive
20402.902.453.423.48%62long-term-positive
20504.453.196.173.85%58long-term-positive
COMPANY FUNDAMENTALS

Financial performance and company fundamentals

Reported fields from the current fundamentals snapshot.

Revenue0Total sales reported for the period; compare growth across several periods.
Gross profit0Interpret alongside the company’s history, sector peers, reporting period and data source.
Operating income-6.84MInterpret alongside the company’s history, sector peers, reporting period and data source.
Net income-6.7MInterpret alongside the company’s history, sector peers, reporting period and data source.
EPS (reported period)-6.41Earnings per share for the stored reporting period; confirm whether the figure is quarterly, annual or trailing twelve months before comparing it with valuation multiples.
EPS growth-99.59%Interpret alongside the company’s history, sector peers, reporting period and data source.
EBITDA-6.8MInterpret alongside the company’s history, sector peers, reporting period and data source.
EBIT-6.84MInterpret alongside the company’s history, sector peers, reporting period and data source.
Cash & equivalents14.53MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total assets19.9MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total liabilities8.29MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total debt0Interpret alongside the company’s history, sector peers, reporting period and data source.
Shareholders equity11.61MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current assets15.98MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current liabilities4.76MInterpret alongside the company’s history, sector peers, reporting period and data source.
Operating cash flow-7.97MInterpret alongside the company’s history, sector peers, reporting period and data source.
Capital expenditure0Interpret alongside the company’s history, sector peers, reporting period and data source.
Free cash flow-7.97MCash remaining after operating needs and capital expenditure; can support investment or shareholder returns.
Return on equity-57.67%Profit generated relative to book equity; leverage and one-off gains can distort it.
Return on assets-33.65%Interpret alongside the company’s history, sector peers, reporting period and data source.
Debt / equity0Debt relative to shareholder equity; definitions may vary by data provider.
Price / book0.16Interpret alongside the company’s history, sector peers, reporting period and data source.
Earnings yield-356.11%Interpret alongside the company’s history, sector peers, reporting period and data source.
Shares outstanding1,060,678Interpret alongside the company’s history, sector peers, reporting period and data source.
Book value / share10.95Interpret alongside the company’s history, sector peers, reporting period and data source.
FCF / share-7.51Interpret alongside the company’s history, sector peers, reporting period and data source.
Market cap3.26MMarket value of outstanding shares, not the same as enterprise value.
P/E ratio1.14Share price relative to earnings per share; interpret alongside growth and peers.
52-week high29.70Highest stored price over the rolling year; not a fair-value estimate.
52-week low1.37Lowest stored price over the rolling year; not a support guarantee.
Average volume8,400Typical shares traded; helps assess liquidity but can change around events.
TECHNICALS

Technical indicators

Latest stored daily indicator snapshot; unavailable indicators are omitted.

Oct 20, 2026
RSI (14)28.81Momentum oscillator from 0–100; extreme readings are context, not automatic buy/sell signals.
SMA 201.79Average closing price over about 20 trading sessions; a short-term trend reference.
SMA 502.17Average closing price over about 50 sessions; often used to assess medium-term direction.
SMA 1003.35Interpret alongside the company’s history, sector peers, reporting period and data source.
SMA 2004.70Average closing price over about 200 sessions; a longer-term trend reference.
EMA 201.80Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 502.29Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 2007.76Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD-0.15Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD signal-0.16Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD histogram0.02Difference between MACD and its signal line; sign and changes indicate momentum shifts.
Bollinger upper1.96Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger middle1.79Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger lower1.62Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic2.5Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic signal2.6351344496816327Interpret alongside the company’s history, sector peers, reporting period and data source.
Williams %R-97.5Interpret alongside the company’s history, sector peers, reporting period and data source.
CCI-221.82Interpret alongside the company’s history, sector peers, reporting period and data source.
MFI60.54Interpret alongside the company’s history, sector peers, reporting period and data source.
ROC-10.23%Interpret alongside the company’s history, sector peers, reporting period and data source.
OBV13.16MInterpret alongside the company’s history, sector peers, reporting period and data source.
Momentum-12.22Interpret alongside the company’s history, sector peers, reporting period and data source.
Volatility+41.03%Interpret alongside the company’s history, sector peers, reporting period and data source.
ATR0.09Average true range estimates recent price movement size, not direction.
ADX19.23Measures trend strength, not whether the trend is bullish or bearish.
Support level1.57Interpret alongside the company’s history, sector peers, reporting period and data source.
Resistance level1.98Interpret alongside the company’s history, sector peers, reporting period and data source.
TrendbearishInterpret alongside the company’s history, sector peers, reporting period and data source.
REPORTED RESULTS

Financial statements, earnings history and estimate revisions

Recent normalized financial statement records.

Showing up to 60 recent statement records. Reported periods and statement types are preserved; blank values are not estimated. Contradictory zero sentinels are withheld instead of presented as verified facts.

PeriodStatementFiscal periodBasisRevenueCost of revenueGross profitOperating incomeNet incomeBasic EPSDiluted EPSCashTotal assetsTotal liabilitiesDebtEquityOperating cash flowCapexFree cash flowSource
Mar 31, 2026balance sheetFY-2026-Q1quarterly———————14.53M19.9M8.29M011.61M———3spread
Mar 31, 2026cash flowFY-2026-Q1quarterly————————————-7.97M0-7.97M3spread
Mar 31, 2026income statementFY-2026-Q1quarterly000-6.84M-6.7M-6.41-6.41————————3spread
Dec 31, 2025balance sheetFY-2025-Q4quarterly———————21.62M27.19M9.81M017.38M———3spread
Dec 31, 2025cash flowFY-2025-Q4quarterly————————————-5.24M0-5.24M3spread
Dec 31, 2025cash flowFY-2025-Q4annual————————————-25.59M0-25.59M3spread
Dec 31, 2025income statementFY-2025-Q4quarterly0—0-6M0-18.69-18.69————————3spread
Dec 31, 2025income statementFY-2025-Q4annual0—0-26.31M-25.97M-87.27-87.27————————3spread
Sep 30, 2025balance sheetFY-2025-Q3quarterly———————21.06M27M9.6M017.39M———3spread
Sep 30, 2025cash flowFY-2025-Q3quarterly————————————-20.36M0-20.36M3spread
Sep 30, 2025income statementFY-2025-Q3quarterly0—0-7.61M-7.55M-2.23-2.23————————3spread
Jun 30, 2025balance sheetFY-2025-Q2quarterly———————9.41M15.62M9.1M06.52M———3spread
Jun 30, 2025cash flowFY-2025-Q2quarterly————————————-7.09M0-7.09M3spread
Jun 30, 2025cash flowFY-2025-Q2annual————————————-13.67M0-13.67M3spread
Jun 30, 2025income statementFY-2025-Q2annual0—0-12.71M-12.61M-30.84-30.84————————3spread
Jun 30, 2025income statementFY-2025-Q2quarterly0—0-6.23M-6.2M-8.40-8.40————————3spread
Mar 31, 2025balance sheetFY-2025-Q1quarterly———————2.14M8.34M9.82M0-1.47M———3spread
Mar 31, 2025cash flowFY-2025-Q1quarterly————————————-6.58M0-6.58M3spread
Mar 31, 2025income statementFY-2025-Q1quarterly0—0-6.48M-6.41M-1,581.81-1,581.81————————3spread
Dec 31, 2024balance sheetFY-2024-Q4quarterly———————8.71M15.59M10.84M04.76M———3spread
Dec 31, 2024cash flowFY-2024-Q4annual————————————-23.79M0-23.79M3spread
Dec 31, 2024cash flowFY-2024-Q4quarterly————————————-5.76M0-5.76M3spread
Dec 31, 2024income statementFY-2024-Q4quarterly0—0-6.38M-6.31M-22.86-22.86————————3spread
Dec 31, 2024income statementFY-2024-Q4annual0—0-24.6M-24.13M-31,460.23-31,460.23————————3spread
Sep 30, 2024balance sheetFY-2024-Q3quarterly———————7.75M15.15M10.73M04.42M———3spread
Sep 30, 2024cash flowFY-2024-Q3quarterly————————————-5.22M0-5.22M3spread
Sep 30, 2024income statementFY-2024-Q3quarterly0—0-5.21M-5.1M-357.86-357.86————————3spread
Jun 30, 2024balance sheetFY-2024-Q2quarterly———————8.07M14.92M10.46M04.46M———3spread
Jun 30, 2024cash flowFY-2024-Q2annual————————————-12.8M0-12.8M3spread
Jun 30, 2024cash flowFY-2024-Q2quarterly————————————-6.15M0-6.15M3spread
Jun 30, 2024income statementFY-2024-Q2annual0—0-13.01M-12.72M-4,458.98-4,458.98————————3spread
Jun 30, 2024income statementFY-2024-Q2quarterly0—0-6.02M-5.88M-1,236.96-1,236.96————————3spread
Mar 31, 2024balance sheetFY-2024-Q1quarterly———————10.25M17.63M11.53M06.1M———3spread
Mar 31, 2024cash flowFY-2024-Q1quarterly————————————-6.65M0-6.65M3spread
Mar 31, 2024income statementFY-2024-Q1quarterly0—0-6.98M-6.83M-368.21-368.21————————3spread
Dec 31, 2023balance sheetFY-2023-Q4quarterly———————16.9M24.84M12.62M012.22M———3spread
Dec 31, 2023cash flowFY-2023-Q4quarterly————————————-5.25M0-5.25M3spread
Dec 31, 2023cash flowFY-2023-Q4annual————————————-11.73M0-11.73M3spread
Dec 31, 2023income statementFY-2023-Q4annual0—0-28.88M-17.41M-2,481.70-2,481.70————————3spread
Dec 31, 2023income statementFY-2023-Q4quarterly0—0-6.38M-5.9M-0.48-0.48————————3spread
Sep 30, 2023balance sheetFY-2023-Q3quarterly———————19.11M27.13M12.41M014.72M———3spread
Sep 30, 2023cash flowFY-2023-Q3quarterly————————————-6.24M0-6.24M3spread
Sep 30, 2023income statementFY-2023-Q3quarterly0—0-6.56M-6.33M-22.16-22.16————————3spread
Jun 30, 2023balance sheetFY-2023-Q2quarterly———————21.01M28.91M12.66M016.25M———3spread
Jun 30, 2023cash flowFY-2023-Q2annual————————————-237K0-237K3spread
Jun 30, 2023cash flowFY-2023-Q2quarterly————————————-4.8M0-4.8M3spread
Jun 30, 2023income statementFY-2023-Q2quarterly0—0-8.18M-7.95M-53.95-53.95————————3spread
Jun 30, 2023income statementFY-2023-Q2annual0—0-15.93M-5.18M-37.45-37.45————————3spread
Mar 31, 2023balance sheetFY-2023-Q1quarterly———————25.33M34.97M11.71M023.26M———3spread
Mar 31, 2023cash flowFY-2023-Q1quarterly————————————4.57M04.57M3spread
Mar 31, 2023income statementFY-2023-Q1quarterly0—0-7.76M2.77M11.4511.45————————3spread
Dec 31, 2022balance sheetFY-2022-Q4quarterly———————22.64M34.22M16.24M017.97M———3spread
Dec 31, 2022cash flowFY-2022-Q4annual————————————-16.65M29K-16.68M3spread
Dec 31, 2022cash flowFY-2022-Q4quarterly————————————-5.94M0-5.94M3spread
Dec 31, 2022income statementFY-2022-Q4quarterly0—0-7.68M-4.64M-0.91-0.91————————3spread
Dec 31, 2022income statementFY-2022-Q4annual0—0-28.64M8.03M1.571.57————————3spread
Sep 30, 2022balance sheetFY-2022-Q3quarterly———————22.15M31.7M15.93M015.76M———3spread
Sep 30, 2022cash flowFY-2022-Q3quarterly————————————-6.9M4K-6.9M3spread
Sep 30, 2022income statementFY-2022-Q3quarterly0—0-7.78M-7.64M-1.53-1.53————————3spread
Jun 30, 2022balance sheetFY-2022-Q2quarterly———————29.43M38.8M15.75M023.05M———3spread

Financial metric history

PeriodRevenue growthGross marginOperating marginNet marginROEROIC
Mar 31, 2026————-57.67%—

Earnings history

These are SEC-reported financial facts grouped by fiscal period. The displayed date is the SEC filing/observation date, not a verified earnings announcement or release date. Use the company’s investor-relations calendar for confirmed earnings-release timing.

SEC filing / observation dateFiscal periodEPS reportedEPS estimateRevenue reportedRevenue estimate
Aug 14, 2026Q2-5.31———
May 13, 2026Q1-6.41———
Mar 26, 2026FY-87.27———
Nov 6, 2025Q3-2.23———
Aug 11, 2025Q2-8.40———
May 15, 2025Q1-4.39———
VALUATION

Stock valuation: P/E, forward P/E and multiples

Multiples shown only when the database has a usable value.

P/E ratio1.14
Price / book0.16
Enterprise value-12.62M

Peer comparisons are withheld until a comparable industry group and a reliable peer set are verified.

LATEST DEVELOPMENTS

News and company updates

Stories linked to this stock in the current database.

RISK CONTEXT

Risk and performance profile

Computed risk/performance records; not a recommendation. Mathematically uninterpretable or extreme ratios are withheld rather than displayed as reliable facts.

Volatility+43.22%
Beta1.19
ATR0.09
Maximum drawdown-94.60%
Sharpe ratio-2.63
Sortino ratio-2.26
Debt / equity0
Current ratio3.36
1-day return-2.17%
5-day return+1.99%
1-month return+3.16%
3-month return-59.84%
6-month return-56.95%
YTD return-80.97%
1-year return-93.03%
All-time return-94.99%
RESEARCH EVIDENCE

Source data and research records

Expandable evidence tables keep the main page focused while preserving detailed data.

Institutional holders and ownership

Showing up to 50 recent holder records. Values failing a basic implied-price check are withheld, not silently corrected.

PeriodFiledHolderCIKSharesValueOwnershipShares changeChange %Source
Jun 30, 2026Aug 13, 2026VANGUARD CAPITAL MANAGEMENT LLC210011912,71356.45K———SEC_13F_DATASET
Jun 30, 2026Jul 23, 2026SBI Securities Co., Ltd.1851815109484———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026GEODE CAPITAL MANAGEMENT, LLC12147177,93335.22K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026OSAIC HOLDINGS, INC.16770443601.6K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026UBS Group AG16105207083.14K———SEC_13F_DATASET
Jun 30, 2026Aug 10, 2026DANSKE BANK A/S80017714———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026BARCLAYS PLC31206931138———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026VANGUARD FIDUCIARY TRUST CO9334784,14218.39K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026GSA CAPITAL PARTNERS LLP136203321,539Withheld: value fails validation———SEC_13F_DATASET
Dec 31, 2025Feb 13, 2026Citigroup Inc.8310012,756Withheld: value fails validation———SEC_13F_HR
Sep 30, 2025Nov 12, 2025Blackrock, Inc.20123831Withheld: value fails validation———SEC_13F_HR
Sep 30, 2025Nov 10, 2025Citigroup Inc.83100174Withheld: value fails validation———SEC_13F_HR
Dec 31, 2016Jul 27, 2026RAFFA WEALTH MANAGEMENT, LLC1631073615———SEC_13F_DATASET
Sep 30, 2016Jul 27, 2026RAFFA WEALTH MANAGEMENT, LLC1631073615———SEC_13F_DATASET
PeriodShares outstandingInstitutional ownershipInsider ownership
Jun 30, 20261,060,678+4.48%—
SEC filings

Showing up to 30 latest filings. Open the original SEC document when a URL is available.

FiledAcceptedFormDescriptionReporting periodAccessionSEC document
Oct 14, 2026—8-K8-KOct 14, 20260001193125-26-421076View filing
Sep 24, 2026—8-K8-KSep 24, 20260001193125-26-400213View filing
Sep 23, 2026—8-K8-KSep 22, 20260001193125-26-399545View filing
Sep 3, 2026—8-K8-KSep 3, 20260001193125-26-381098View filing
Aug 31, 2026—DEF 14ADEF 14ASep 22, 20260001193125-26-376763View filing
Aug 21, 2026—S-1S-1—0001193125-26-361103View filing
Aug 21, 2026—8-K8-KAug 21, 20260001193125-26-361079View filing
Aug 14, 2026—10-Q10-QJun 30, 20260001193125-26-350559View filing
Aug 14, 2026—8-K8-KAug 14, 20260001193125-26-350537View filing
Aug 13, 2026—8-K8-KAug 12, 20260001193125-26-349380View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343069View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343067View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343065View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343080View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343079View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343077View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343076View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343073View filing
Aug 10, 2026—44Aug 6, 20260001193125-26-343072View filing
Aug 10, 2026—44Jul 17, 20260001193125-26-343070View filing
Jul 31, 2026—DEF 14ADEF 14AJul 31, 20260001193125-26-328604View filing
Jul 27, 2026—8-K8-KJul 27, 20260001193125-26-318056View filing
Jun 30, 2026—8-K8-KJun 29, 20260001193125-26-290473View filing
Jun 22, 2026—3PRIMARY DOCUMENTMay 25, 20260001666270-26-000003View filing
May 28, 2026—33May 20, 20260001193125-26-245818View filing
May 27, 2026—8-K8-KMay 25, 20260001193125-26-241867View filing
May 13, 2026—10-Q10-QMar 31, 20260001193125-26-221661View filing
May 13, 2026—8-K8-KMay 13, 20260001193125-26-221593View filing
May 6, 2026—8-K8-KMay 6, 20260001193125-26-208958View filing
Mar 26, 2026—10-K10-KDec 31, 20250001193125-26-126278View filing
Quarterly and monthly research
PeriodResearch summary
Mar 31, 2026Derived quarterly snapshot; AI narrative pending
Mar 31, 2026Latest reported fundamentals for fiscal period FY-2026-Q1. Revenue: $0. EPS: $-6.410. EPS growth: -99.59%. Gross margin: NaN%. Operating margin: -Infinity%. Net margin: -Infinity%. Free cash flow: $-7965000.
MonthResearch summary
Oct 1, 2026Derived monthly snapshot; AI narrative pending
Third-party metrics and ratios

Showing up to 40 recent metric records and 40 ratio records from the query window. Provider periods, units and validity flags are preserved when available.

PeriodReport periodFiscal yearQuarterPeriod typeCategoryValueUnitCurrencyValidSource
Jun 30, 2026Jun 30, 202620262semiannualgeneral_and_administrative-5,660,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualresearch_and_development-7,620,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcommon_stock114,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262instantaccounts_payable1,162,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantaccrued_expenses3,107,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantadditional_paid_in_capital294,191,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcash_and_equivalents9,797,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualcash_beginning_of_period21,619,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualcash_end_of_period9,797,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_accounts_payable285,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_accrued_liabilities-1,146,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_other_liabilities-688,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_prepaid_expenses460,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcurrent_assets10,798,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcurrent_liabilities5,188,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualdepreciation_and_amortization67,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualeps_basic-11.19USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualeps_diluted-11.19USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantlease_liability_current4,209,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_financing1,597,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_investing0USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_operating-13,419,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_change_in_cash-11,822,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_income-13,053,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_income_starting_line-13,053,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_income_to_common-97,000ratioUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantnet_property_plant_equipment236,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnon_cash_investing_and_financing97,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnon_cash_lease_expense541,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualoperating_income-13,280,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantoperating_lease_right_of_use_asset3,484,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualother_below_net_income-97,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualother_non_operating_income227,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantprepaid_expenses1,001,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualproceeds_from_stock_issuance1,598,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantretained_earnings-288,264,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualshares_basic1,175,450sharesUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualshares_diluted1,175,450sharesUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualstock_based_compensation115,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualtax_withholding_on_share_settlement-1,000USDUSDYes3Spread
PeriodReport periodFiscal yearQuarterPeriod typeRatio categoryRatioValuePercentileMissing inputsValidSource
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyasset_turnover0+0.00%revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowcf_margin_pct0+0.00%revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlysectorebitda_margin_pct0+0.00%revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilitygross_margin_pct0+0.00%gross_profit,revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilitynet_margin_pct0+0.00%revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityoperating_margin_pct0+0.00%revenueNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyreceivables_turnover0+0.00%revenue,receivablesNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquiditycash_ratio1.89+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowcf_to_net_income0.86+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquiditycurrent_ratio2.08+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleveragedebt_to_assets0.58+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlysectordebt_to_ebitda-1.32+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleveragedebt_to_equity1.4+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleverageequity_multiplier2.4+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowfree_cash_flow-5,454,000+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowoperating_cf_ratio-1.05+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquidityquick_ratio2.08+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityroa_pct-43.78+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityroe_pct-105.21+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquidityworking_capital5,610,000+0.00%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyasset_turnover0+0.00%revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowcf_margin_pct0+0.00%revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlysectorebitda_margin_pct0+0.00%revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilitygross_margin_pct0+0.00%gross_profit,revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilitynet_margin_pct0+0.00%revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilityoperating_margin_pct0+0.00%revenueNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyreceivables_turnover0+0.00%revenue,receivablesNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyliquiditycash_ratio3.05+87.95%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowcf_to_net_income1.19+61.18%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyliquiditycurrent_ratio3.36+74.89%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleveragedebt_to_assets0.42+35.71%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlysectordebt_to_ebitda-1.22+28.56%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleveragedebt_to_equity0.71+46.47%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleverageequity_multiplier1.71+43.54%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowfree_cash_flow-7,965,000+30.77%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowoperating_cf_ratio-1.67+4.83%—Yes3Spread
Data quality and provenance

This page does not fill gaps with sample data. Values shown above come from the connected market-data and research tables.

No verified records available for this section yet.
RetrievedDatasetProviderStatus
Oct 8, 2026company_profileUS Market AI / SEC-mapped universeVerified
Identifiers and model evaluation
IdentifierValueSource
cik1671584stocks.cik
tickerAPVOstocks.symbol
No verified records available for this section yet.
QUICK ANSWERS

Frequently asked questions

What is APVO stock's current price?

The latest stored quote for APVO is 1.60. The quote timestamp is 10/19/2026, 4:00:00 AM. Prices can change during market hours.

What is the APVO stock forecast and analysis?

The latest available quantitative model signal is “neutral”. Review the forecast horizons alongside the company's reported financials, valuation, technical indicators and risks below; model outputs are estimates, not guarantees or personalized investment advice.

What is the APVO stock price target?

The forecast table shows stored quantitative model outputs for the available horizons. These are model targets, not necessarily Wall Street analyst consensus; a verified consensus target is not assumed unless explicitly stored.

What is the APVO stock price prediction for 2030?

A stored long-term model scenario for 2030 is shown in the forecast table. Long-range scenarios are highly uncertain and should be reviewed alongside the model version and assumptions.

What are the bullish and bearish views on APVO?

A sufficiently detailed analyst-opinion dataset is not currently stored for this stock. The bull and bear cases on this page are conditional evidence-based scenarios, not attributed analyst recommendations.

What is the APVO stock price prediction for 2026?

A verified 2026 long-term model output is not currently stored for this stock. Check the forecast section for available horizons rather than relying on an unsupported target.

Is APVO stock overvalued or undervalued?

The latest stored trailing P/E is 1.14. Those multiples alone cannot establish fair value; compare growth, cash flow, earnings quality, risk and relevant peers.

What is APVO's P/E ratio?

The latest stored trailing P/E ratio is 1.14. P/E compares share price with earnings per share and should be interpreted alongside growth, cyclicality and accounting quality.

What is APVO's 52-week high and low?

The stored 52-week range is 1.37 to 29.70. This describes the recent trading range, not a forecast or a guaranteed support/resistance level.

Does APVO pay a dividend, and what is its dividend history?

No dividend records are currently stored for this stock. That absence does not prove the company pays no dividend.

When is APVO's next earnings report?

The latest SEC filing/observation date in this database is Aug 14, 2026. This is not a verified earnings announcement date or a confirmed next-report date; check company investor relations for the official calendar.

How has APVO stock performed recently?

The price chart uses 250 stored daily observations, and the market snapshot includes the latest available quote. Use the chart to inspect the period shown; past performance does not predict future returns.

Is APVO stock in a bullish or bearish trend?

The stored technical snapshot classifies the trend as “bearish”. This rule-based label is based on available indicators and is not a standalone buy or sell signal.

What are the main risks of investing in APVO?

Available risk metrics are shown in the risk and performance section. These metrics do not capture every business, competitive, regulatory or market risk; review company filings and disclosures as well.

Where can I find APVO's financial statements and earnings history?

Use the Financial Statements section for stored statement records, financial metric history, earnings results and estimate revisions. Coverage depends on the data available for this company.

Does US Market AI provide a guaranteed APVO price target?

No. Forecasts shown here are quantitative model outputs, not guarantees or personalized financial advice. Missing forecast values are left unavailable rather than filled with invented targets.

KEEP EXPLORING

Related Healthcare stocks

Other active stocks in this sector. This is a directory, not a performance ranking.

Browse all stocks ↗
LLYEli Lilly & Co.Healthcare1.05T market capJNJJohnson & JohnsonHealthcare630.04B market capABBVABBVIE INC.Healthcare483B market capMRKMerck & Co., Inc.Healthcare359.22B market cap
US MARKET AI · STOCK RESEARCH

Data availability varies by company and provider. Missing values are omitted rather than estimated. Forecasts are model outputs and should be independently evaluated.

Research updated Oct 19, 2026 · Research methodology · Disclaimer